116 3rd St SE
Cedar Rapids, Iowa 52401
COVID-19 vaccines for children ages 5 to 11 could be available by next month, some experts anticipate.
The U.S. Food and Drug Administration is reviewing the application from Pfizer-BioNTech to authorize its two-dose vaccine for younger children, with a panel of experts expected to discuss the topic on Oct. 26.
Advisers to the Centers for Disease Control and Prevention are expected to meet on the recommendations Nov. 2 and Nov. 3. A final decision from federal health officials is expected shortly after.
The Gazette wants to know what questions our readers are asking about this news. Submit them in the form above or to the left of this paragraph.
Don’t see the form? Click here.
What do you want to know about this federal approval process for vaccinating younger children? Do you have questions about COVID-19 vaccines for children 5 to 11, or for children in general?
Send us your questions in this form, and we’ll ask local health care providers and other experts.
Comments: (319) 398-8469; email@example.com